Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2013 Aug 26;8(8):e71771. doi: 10.1371/journal.pone.0071771

Genetic Variants at 20p11 Confer Risk to Androgenetic Alopecia in the Chinese Han Population

Bo Liang 1,2,3,#, Chunjun Yang 1,2,3,#, Xianbo Zuo 1,2,3,#, Yang Li 1,2,3,#, Yantao Ding 1,2,3, Yujun Sheng 1,2,3, Fusheng Zhou 1,2,3, Hui Cheng 1,2,3, Xiaodong Zheng 1,2,3, Gang Chen 1,2,3, Zhengwei Zhu 1,2,3, Jun Zhu 1,2,3, Xuhui Fu 1,2,3, Tao Wang 1,2,3, Ying Dong 1,2,3, Dawei Duan 1,2,3, Xianfa Tang 1,2,3, Huayang Tang 1,2,3, Jinping Gao 1,2,3, Liangdan Sun 1,2,3, Sen Yang 1,2,3, Xuejun Zhang 1,2,3,*
Editor: Qingyang Huang4
PMCID: PMC3753324  PMID: 23990985

Abstract

Background

Androgenetic alopecia (AGA) is a well-characterized type of progressive hair loss commonly seen in men, with different prevalences in different ethnic populations. It is generally considered to be a polygenic heritable trait. Several susceptibility genes/loci, such as AR/EDA2R, HDAC9 and 20p11, have been identified as being involved in its development in European populations. In this study, we aim to validate whether these loci are also associated with AGA in the Chinese Han population.

Methods

We genotyped 16 previously reported single nucleotide polymorphisms (SNPs) with 445 AGA cases and 546 healthy controls using the Sequenom iPlex platform. The trend test was used to evaluate the association between these loci and AGA in the Chinese Han population. Conservatively accounting for multiple testing by the Bonferroni correction, the threshold for statistical significance was P ≤3.13×10−3.

Results

We identified that 5 SNPs at 20p11 were significantly associated with AGA in the Chinese Han population (1.84×10−11≤P≤2.10×10−6).

Conclusions

This study validated, for the first time, that 20p11 also confers risk for AGA in the Chinese Han population and implicated the potential common genetic factors for AGA shared by both Chinese and European populations.

Introduction

Androgenetic alopecia (AGA) is a common disease that is characterized by a distinctive pattern of progressive hair loss from the scalp. The proportion of affected males increases steadily with age, and its high prevalence in older men suggests that this form of hair loss may be a normal consequence of aging [1], [2]. The prevalence of AGA is different among races. The prevalence of AGA in Chinese males is lower than in Caucasians at all ages [3], [4].

The etiology of AGA was first described by Hamilton, including two essential components: genetic predisposition and hormone dependency [5], [6]. So far, several genetic factors, such as the androgen receptor (AR)/the ectodysplasin A2 receptor (EDA2R) [7][10], histone deacetylase 9 (HDAC9) [11] and 20p11 [12], [13], have been identified as being associated with this disorder. The present study aims to investigate whether the known susceptibility loci for the European populations are also associated with AGA in the Chinese Han population by the investigation of 8 SNPs at HDAC9 [11], 5 SNPs on 20p11 [13] and 3 SNPs at the AR/EDA2R locus [9], [10].

Materials and Methods

Samples and DNA extraction

This investigation involved samples from 445 affected cases and 546 controls. All participants were males of Chinese Han descent (Table 1). The hair status of all participants was assessed by dermatologists according to the Hamilton/Norwood (HN) classification system. Affected men were <30 years of age with AGA grades IV–VII or <40 years with AGA grades V–VII. The controls comprised 546 unaffected male controls aged >60 years. Blood samples were collected in tubes containing disodium ethylene diamine tetraacetic acid (EDTA) as an anticoagulant and stored at −80°C until extraction. Genomic DNA was extracted from peripheral blood lymphocytes using Flexi Gene DNA kits (Qiagen, Hilden, Germany) according to standard procedures and diluted to working concentrations of 20 ng/μl for the replication study of the findings in the European population. All the samples were obtained after written informed consent. The study was approved by the Ethics Committee of Anhui Medical University and conducted according to Declaration of Helsinki Principles.

Table 1. Summary of AGA cases and controls.

Characteristic Cases a Controls b
Total number 445 546
Age (years) 28.38±4.43 65.72±4.67

Note:

a

Effected men were <30 years of age with AGA grades IV–VII or <40 years with AGA grades V–VII.

b

The controls comprised unaffected male controls aged >60 years.

Genotyping

Genotyping was performed in multiplex reactions using the MassArray system and a Sequenom Compact MALDI-TOF device (Sequenom Inc., San Diego, CA, U.S.A.) at the Key Lab of Dermatology, Ministry of Education, Anhui Medical University, China. For the association analysis, the minor allele frequency (MAF) was ≥1% with P ≥0.05 for Hardy-Weinberg equilibrium in the controls, and SNPs with call rates higher than 95% in cases or controls were used for the SNP quality criteria.

Statistical analysis

For the association testing, the Armitage trend test was used to detect allelic and genotypic effects using Plink 1.07 software (Harvard, Boston, MA, USA). The power was calculated using the power Fisher exact test in SPSS (SPSS version 13.0). In total, 16 SNPs were genotyped in 445 cases and 546 controls. Conservatively accounting for multiple testing by the Bonferroni correction, the threshold for statistical significance was P≤3.13×10−3.

Results

Overall, we genotyped 16 SNPs in this study, which was performed in 445 AGA cases and 546 controls of Chinese Han descent using the Sequenom MassArray system. As shown in Table 2, the 3 SNPs (rs1385699, rs2497911, rs5919393) of the AR/EDA2R locus, which shows significant association with AGA in European populations, were monomorphic in the Chinese population. The 8 SNPs of the HDAC9 locus, which reported susceptibility to AGA from a previous GWAS in European populations, showed no significance in the Chinese Han Population. After the initial analysis using the Armitage trend test, 5 SNPs (rs2180439, rs1998076, rs6113491, rs6137444 and rs201571) were significantly associated with AGA, exceeding the threshold of statistical significance for association (P<3.13×10−3).These five AGA susceptibility SNPs identified in the Chinese population are associated with one genetic locus (20p11). The SNP rs2180439 showed a stronger association (OR  = 1.92, P = 1.84×10−11) than the other four SNPs. Furthermore, controlling for the genetic effect of the SNP rs2180439 by using conditional logistic regression analysis also abolished the association of the other four SNPs (P>0.05, Table 3). These findings indicate that the other four SNP alleles are correlated with the SNP rs2180439 and that the association of the other four SNPs is mainly driven by the SNP rs2180439. The difference in the distribution of the rs2180439 genotype between the AGA cases and controls was significant (P = 1.29×10−10) (Table 4).

Table 2. Case-control association analysis for SNPs within AR/EDA2R, HDAC9 and 20p11 in 445 Han Chinese patients with AGA and 546 controls.

SNP Samplea locus Positionb European Chinese Han
Cases Controls Ac/B Allele MAFd (Case/Control) Risk allele Allelic P Risk Allelic OR(95%CI) Ref Ac/B Allele MAFd (Case/Control) Genotypese Risk Allele Allelic Pf Risk Allelic OR(95%CI) Power(%)
Cases Controls
rs6137444 445 546 20p11 21733639 C/T 0.269/0.391 T 2.20×1010 1.74(1.37–2.21) [13] C/T 0.272/0.401 34/174/237 96/246/204 T 1.68×10−9 1.79 (1.49–2.17) 98
rs2180439 444 540 20p11 21801100 C/T 0.293/0.452 T 2.67×1015 1.82(1.45–2.30) C/T 0.271/0.417 29/183/232 108/234/198 T 1.84×10−11 1.92(1.59–2.33) 99
rs1998076 445 540 20p11 21828045 A/G 0.292/0.448 G 7.73×1015 1.9(1.50–2.41) A/G 0.270/0.411 29/182/234 102/240/198 G 5.28×10−11 1.89(1.56–2.27) 99
rs201571 443 546 20p11 21961514 C/T 0.298/0.44 T 1.21×1012 1.72(1.36–2.17) T/C 0.428/0.324 77/225/141 72/210/264 T 2.10×10−6 1.56(1.30–1.87) 97
rs6113491 445 546 20p11 22005415 A/C 0.641/0.488 A 1.13×1013 1.66(1.33–2.08) A/C 0.425/0.313 81/216/148 66/210/270 A 2. 82×10−7 1.62(1.35–1.95) 98
rs3852255 445 546 HDAC9 18832972 T/C 0.045/0.030 T 1.45×101 1.54(0.87–2.72) [11] T/C 0.136/0.143 10/101/334 6/144/396 C 6.59×10−1 1.06(0.82∼1.37) 70
rs13230142 445 534 HDAC9 18848034 A/G 0.030/0.013 A 3.10×102 2.37(1.05–5.37) A/G 0.117/0.118 8/88/349 6/114/414 G 9.39×10−1 1.01(0.77∼1.33) 90
rs12056282 443 540 HDAC9 18848728 C/T 0.043/0.022 C 2.90×102 1.98(1.05–3.75) C/T 0.135/0.144 11/98/334 6/144/390 T 5.67×10−1 1.08(0.83∼1.39) 95
rs756853 442 534 HDAC9 18856525 G/A 0.496/0.380 G 4.65×106 1.61(1.30–1.98) A/G 0.397/0.410 68/215/159 90/258/186 G 5.59×10−1 1.05(0.88∼1.27) 92
rs2249817 445 540 HDAC9 18862536 G/A 0.475/0.411 G 8.90×106 1.59(1.29–1.95) A/G 0.300/0.267 39/189/217 42/204/294 A 1.02×10−1 1.18(0.97∼1.44) 82
rs10247184 445 546 HDAC9 18879472 T/C 0.002/0 T 3.34×101 T/C 0.123/0.137 9/91/345 18/114/414 T 3.28×10−1 1.14(0.88∼1.49) 90
rs10252945 441 528 HDAC9 18891375 A/C 0.286/0.256 A 1.97×101 1.17(0.92–1.47) A/C 0.231/0.222 19/166/256 36/162/330 A 6.11×10−1 1.06(0.85∼1.31) 52
rs17350355 444 546 HDAC9 18895028 A/G 0.441/0.354 A 5.81×104 1.44(1.17–1.78) A/G 0.389/0.412 68/209/167 102/246/198 G 2.87×10−1 1.10(0.92∼1.32) 36
rs1385699 445 546 AR/EDA2R 65741711 C/T 0.113/0.292 T 1.60×105 3.23(1.86–5.59) [9] T/T 1.000/1.000 445 546 NA NA NA
rs5919393 445 546 AR/EDA2R 66742082 C/T 0.046/0.218 T 6.00×107 5.82(2.73–12.41) T/T 1.000/1.000 445 546 NA NA NA
rs2497911 445 546 AR/EDA2R 66544165 A/C 0.038/0.283 C 2.30×104 [10] C/C 1.000/1.000 445 546 NA NA NA

Note:

a, Total samples (445 cases and 546 controls), some samples failed to genotype in the experiment;.

b, In bp. NCBI build 36.3;.

c, Minor allele;.

d, MAF =  Minor allele frequency;.

e, Numbers shown correspond to the following genotypes: AA/AB/BB (A = minor allele; B =  major allele).

f, the threshold for statistical significance was P≤3.13×10−3.

Table 3. Association and conditional logistic analysis for rs2180439, rs6137444, rs1998076, rs201571 and rs6113491 in 445 cases and 546 controls.

SNP CHR Positiona Risk Allele Risk Allele Frequency Allelic P OR(95%CI) Condition rs2180439
Case Control P OR(95%CI)
rs2180439 20 21801100 T 0.729 0.417 1.84×10–11 1.92(1.59–2.33)
rs6137444 20 21733639 T 0.728 0.401 1.68×10–9 1.79(1.49–2.17) 7.22×10–1 1.09(0.70–1.67)
rs1998076 20 21828045 G 0.73 0.411 5.28×10–11 1.89(1.56–2.27) 7.43×10–1 1.14(0.53–2.44)
rs201571 20 21961514 T 0.428 0.324 2.10×10–6 1.56(1.30–1.87) 9.89×10–2 1.19(0.97–1.47)
rs6113491 20 22005415 A 0.425 0.313 2. 82×10–7 1.62(1.35–1.95) 5.38×10–2 1.26(0.99–1.55)

Note:

a, In bp. NCBI build 36.3.

Table 4. Genotypic effects analysis for rs2180439 in the AGA patients and controls.

Cases (n = 445) Controls (n = 546) OR (95%CI) P
Genotype CC 29(6.53%) 108(20%) Reference 1.29×10−10
TC 183(41.22%) 234(43.33%) 2.91(1.85–4.58)
TT 232(52.25%) 198(36.67%) 4.36(2.78–6.85)

Discussion

This study is the first to investigate the contribution of the major AGA susceptibility loci AR/ EDA2R, 20p11 and HDAC9 to the development of AGA in the Chinese Han population.

In this study, we confirmed that the susceptibility locus 20p11 for AGA in the Chinese Han population, which suggested the existence of common genetic factors shared for AGA in diverse ethnic populations. Because a gene contributing to the development of AGA would be expected to be expressed in the human scalp, Hillmer AM et al quantified the gene expression of the 20p11 locus and the expression of the closest paired box 1 (PAX1) gene [13]. The results showed that PAX1 was expressed at very high levels in the scalp skin. Although the PAX1 gene is more than 100 kb away from the 20p11–associated LD block, the expression data might suggest that PAX1 confers the AGA-relevant effect at this locus and that a regulatory variant within the associated LD block may modulate its expression through long-range control. However, demonstration of the influence of the chromosome 20p11.22 locus on the transcription of the PAX1 gene requires further investigation.

For the HDAC9 locus, the statistical power calculations showed that we had >80% power to detect 5 SNPs (rs13230142, rs12056282, rs756853, rs2249817 and rs10247184) associated with AGA, whereas other 3 SNPs (rs3852255, rs10252945 and rs17350355) had low power (≤70%), with SNP rs17350355 having the lowest power (36%). For those SNPs that had low power to detect an association, we could not confirm that these SNPs lacked an association with AGA because we might lack the power to detect a true association. Larger sample sizes will help improve the power and ensure the correct conclusion with respect to whether these SNP are associated with AGA. For those SNPs that had >80% power to detect an association, we confirmed that these SNPs are not associated with AGA; however, we do not deny that HDAC9 may be a risk factor for AGA because there could be different functional variants between Chinese and Caucasian populations or different LD patterns between the markers and hidden functional variants. For the AR/EDA2R locus, our genotype data showed that the three SNPs (rs1385699, rs2497911 and rs5919393) of the AR/EDA2R locus that show significant association with AGA in European populations were monomorphic in the Chinese population. These results showed that there is genetic heterogeneity among different populations. Genotyping other known SNPs in these region according to HapMap data will help elucidate the basis for potential ethnicity-related disparities in the AGA association for previously reported loci (HDAC9 and AR/EDA2R) among different populations, which will provide a better understanding of the genetic basis of AGA.

Taken together, our study provided strong genetic evidence for the hypothesis that 20p11 might influence the susceptibility to AGA in both the Chinese Han and European populations, although the role of the 20p11 locus in the pathogenesis of AGA remains unclear. Further study using fine mapping and a functional study are warranted to investigate its exact role in the pathogenesis of AGA.

Acknowledgments

We thank all study participants and all volunteers who so willingly participated in this study, thus making this study possible.

Funding Statement

This work was supported by the General Program of the National Natural Science Foundation of China (30771941/H1106) and CMA-L'OREAL China Skin/Hair Grant (2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1. Hamilton JB (1951) Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53: 708–728. [DOI] [PubMed] [Google Scholar]
  • 2. Norwood OT (1975) Male pattern baldness: classification and incidence. South Med J 68: 1359–1365. [DOI] [PubMed] [Google Scholar]
  • 3. Wang TL, Zhou C, Shen YW, Wang XY, Ding XL, et al. (2010) Prevalence of androgenetic alopecia in China: a community-based study in six cities. Br J Dermatol 162: 843–847. [DOI] [PubMed] [Google Scholar]
  • 4. Xu F, Sheng YY, Mu ZL, Lou W, Zhou J, et al. (2009) Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study. Br J Dermatol 160: 629–32. [DOI] [PubMed] [Google Scholar]
  • 5. Trueb RM (2010) [Hormones and hair growth]. Hautarzt 61: 487–495. [DOI] [PubMed] [Google Scholar]
  • 6. Chumlea WC, Rhodes T, Girman CJ, Johnson-Levonas A, Lilly FR, et al. (2004) Family history and risk of hair loss. Dermatology 209: 33–39. [DOI] [PubMed] [Google Scholar]
  • 7. Brockschmidt FF, Hillmer AM, Eigelshoven S, Hanneken S, Heilmann S, et al. (2010) Fine mapping of the human AR/EDA2R locus in androgenetic alopecia. Br J Dermatol 162: 899–903. [DOI] [PubMed] [Google Scholar]
  • 8. Prodi DA, Pirastu N, Maninchedda G, Sassu A, Picciau A, et al. (2008) EDA2R is associated with androgenetic alopecia. J Invest Dermatol 128: 2268–2270. [DOI] [PubMed] [Google Scholar]
  • 9. Hillmer AM, Hanneken S, Ritzmann S, Becker T, Freudenberg J, et al. (2005) Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet 77: 140–148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Cobb JE, Zaloumis SG, Scurrah KJ, Harrap SB, Ellis JA (2010) Evidence for two independent functional variants for androgenetic alopecia around the androgen receptor gene. Exp Dermatol 19: 1026–8. [DOI] [PubMed] [Google Scholar]
  • 11. Brockschmidt FF, Heilmann S, Ellis JA, Eigelshoven S, Hanneken S, et al. (2011) Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness. Br J Dermatol 165: 1293–1302. [DOI] [PubMed] [Google Scholar]
  • 12. Richards JB, Yuan X, Geller F, Waterworth D, Bataille V, et al. (2008) Male-pattern baldness susceptibility locus at 20p11. Nat Genet 40: 1282–1284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Hillmer AM, Brockschmidt FF, Hanneken S, Eigelshoven S, Steffens M, et al. (2008) Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 40: 1279–1281. [DOI] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES